About BETAHEALTH ETF UNITS

DRUG invests in stocks. The fund's major sectors are Health Technology, with 88.35% stocks, and Health Services, with 10.27% of the basket. The assets are mostly located in the North America region.

DRUG top holdings are Eli Lilly and Company and Johnson & Johnson, occupying 6.95% and 6.29% of the portfolio correspondingly.

DRUG last dividends amounted to 0.03 AUD. Six months before that, the issuer paid 0.22 AUD in dividends, which shows a 717.94% decrease.

DRUG assets under management is ‪169.68 M‬ AUD. It's risen 1.90% over the last month.

DRUG fund flows account for ‪18.65 M‬ AUD (1 year). Many traders use this metric to get insight into investors' sentiment and evaluate whether it's time to buy or sell the fund.

DRUG shares are issued by BetaShares Holdings Pty Ltd. under the brand BetaShares. The ETF was launched on Aug 4, 2016, and its management style is Passive.

DRUG expense ratio is 0.57% meaning you'd have to pay 0.57% of your investment to help manage the fund.

DRUG follows the Nasdaq Global ex-Australia Healthcare Hedged AUD Index - AUD. ETFs usually track some benchmark seeking to replicate its performance and guide asset selection and objectives.

DRUG invests in stocks.

DRUG price has risen by 1.05% over the last month, and its yearly performance shows a −11.86% decrease. See more dynamics on DRUG price chart.
NAV returns, another gauge of an ETF dynamics, showed a −5.50% decrease in three-month performance and has decreased by −8.68% in a year.